Lymph Node Metastasis Clinical Trials

18 recruiting

Lymph Node Metastasis Trials at a Glance

20 actively recruiting trials for lymph node metastasis are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Boston, Brisbane, and Chapel Hill. Lead sponsors running lymph node metastasis studies include Copernicus Memorial Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Brigham and Women's Hospital.

Browse lymph node metastasis trials by phase

Treatments under study

About Lymph Node Metastasis Clinical Trials

Looking for clinical trials for Lymph Node Metastasis? There are currently 18 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymph Node Metastasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymph Node Metastasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Not Applicable

Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response

Prostate AdenocarcinomaOligorecurrenceIliac Nodal Disease+2 more
University Health Network, Toronto26 enrolled1 locationNCT06831032
Recruiting
Not Applicable

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Lung CancerLymph Node MetastasisPathologic Processes
Brigham and Women's Hospital160 enrolled1 locationNCT06252129
Recruiting
Not Applicable

NODE (groiN ultrasOunD cancEr)

Lymph Node MetastasisUltrasound Therapy; ComplicationsVulvar Cancer Stage Ib+2 more
Queensland Centre for Gynaecological Cancer30 enrolled5 locationsNCT06264167
Recruiting
Not Applicable

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

Breast CancerLymph Node Metastasis
UNC Lineberger Comprehensive Cancer Center100 enrolled1 locationNCT07025785
Recruiting
Not Applicable

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

Lymph Node MetastasisThyroid Cancer Patients
Tian'an Jiang85 enrolled1 locationNCT07328243
Recruiting
Not Applicable

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

Lymph Node MetastasisLymph Node Neoplasm
Copernicus Memorial Hospital1,000 enrolled6 locationsNCT06527027
Recruiting

Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer

T1 Gastric Cancer Lymph Node Metastasis Early Gastric Cancer Artificial Intelligence-Assisted Diagnosis Multimodal Data Integration
Qun Zhao300 enrolled1 locationNCT07124754
Recruiting

Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

Lymph Node MetastasisESCCRadiomics
The First Affiliated Hospital of Anhui Medical University500 enrolled1 locationNCT07050576
Recruiting
Not Applicable

Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies

Lymph Node MetastasisGynecologic Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS160 enrolled1 locationNCT06621823
Recruiting

SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes

Head and Neck CancerLymph Node MetastasisLymphoma
Rigshospitalet, Denmark100 enrolled2 locationsNCT05754814
Recruiting
Phase 1

Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas

Head and Neck Squamous Cell CarcinomaLymph Node Metastasis
MegaPro Biomedical Co. Ltd.24 enrolled1 locationNCT06540443
Recruiting

A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)

Lymph Node MetastasisNasopharyngeal Cancinoma (NPC)
Sun Yat-sen University500 enrolled1 locationNCT06829147
Recruiting
Not Applicable

Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC

Lymph Node MetastasisOral Cancer
Huashan Hospital300 enrolled1 locationNCT06623266
Recruiting
Not Applicable

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Lymph Node MetastasisPapillary Thyroid CancerCarcinogenesis
Second Affiliated Hospital of Xi'an Jiaotong University170 enrolled1 locationNCT06468696
Recruiting

Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.

Cervical CancerLymph Node MetastasisArtificial Intelligence
Obstetrics & Gynecology Hospital of Fudan University4,000 enrolled1 locationNCT06448897
Recruiting

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Lymph Node MetastasisLiquid BiopsySquamous Cell Carcinoma of the Oropharynx+3 more
Regina Elena Cancer Institute142 enrolled1 locationNCT05918510
Recruiting

Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer

Breast CancerLymph Node Metastasis
Shantou Central Hospital2,400 enrolled1 locationNCT06001528
Recruiting
Not Applicable

Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer

Lymph Node MetastasisPancreas CancerPancreas Adenocarcinoma
Jon Unosson300 enrolled6 locationsNCT06065891
Recruiting
Phase 3

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

Lymph Node MetastasisLung Adenocarcinoma
Fudan University634 enrolled1 locationNCT06031246
Recruiting

Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion

Lung CancerLymph Node Metastasis
Luzerner Kantonsspital958 enrolled1 locationNCT05596578